Modeling excess hazard with time-to-cure as a parameter.

Cure models have been widely developed to estimate the cure fraction when some subjects never experience the event of interest. However these models were rarely focused on the estimation of the time-to-cure i.e. the delay elapsed between the diagnosis and "the time from which cure is reached", an important indicator, for instance to address the question of access to insurance or loans for subjects with personal history of cancer. We propose a new excess hazard regression model that includes the time-to-cure as a covariate dependent parameter to be estimated. The model is written similarly to a Beta probability distribution function and is shown to be a particular case of the non-mixture cure models. Parameters are estimated through a maximum likelihood approach and simulation studies demonstrate good performance of the model. Illustrative applications to three cancer data sets are provided and some limitations as well as possible extensions of the model are discussed. The proposed model offers a simple and comprehensive way to estimate more accurately the time-to-cure. This article is protected by copyright. All rights reserved.

[1]  Paul W Dickman,et al.  Estimating and modeling the cure fraction in population-based cancer survival analysis. , 2007, Biostatistics.

[2]  Anthony Y. C. Kuk,et al.  A mixture model combining logistic regression with proportional hazards regression , 1992 .

[3]  Jorge Nocedal,et al.  A Limited Memory Algorithm for Bound Constrained Optimization , 1995, SIAM J. Sci. Comput..

[4]  Yingwei Peng,et al.  Accelerated hazards mixture cure model , 2009, Lifetime data analysis.

[5]  V. Farewell,et al.  The use of mixture models for the analysis of survival data with long-term survivors. , 1982, Biometrics.

[6]  R. Maller,et al.  Survival Analysis with Long-Term Survivors , 1996 .

[7]  J G Ibrahim,et al.  Estimating Cure Rates From Survival Data , 2003, Journal of the American Statistical Association.

[8]  J. Klein,et al.  Statistical Models Based On Counting Process , 1994 .

[9]  W. Newey,et al.  Large sample estimation and hypothesis testing , 1986 .

[10]  Chris McDonald,et al.  CANSURV: A Windows program for population-based cancer survival analysis , 2005, Comput. Methods Programs Biomed..

[11]  Paul W Dickman,et al.  Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models , 2011, BMC medical research methodology.

[12]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[13]  Joseph G. Ibrahim,et al.  Semiparametric Transformation Models for Survival Data With a Cure Fraction , 2006 .

[14]  J. Ibrahim,et al.  Handbook of survival analysis , 2014 .

[15]  Joseph G. Ibrahim,et al.  A New Bayesian Model For Survival Data With a Surviving Fraction , 1999 .

[16]  R. Sankaranarayanan,et al.  [Population-based cancer survival: an analysis of 16,922 cases]. , 1998, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[17]  M. Federico,et al.  Long-term survival, prevalence, and cure of cancer: a population-based estimation for 818 902 Italian patients and 26 cancer types , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  F. Berrino,et al.  The cure for colon cancer: Results from the EUROCARE study , 1998, International journal of cancer.

[19]  Sudipto Banerjee,et al.  Analysis of cure rate survival data under proportional odds model , 2011, Lifetime data analysis.

[20]  V. Jooste,et al.  A new approach to estimate time-to-cure from cancer registries data. , 2018, Cancer epidemiology.

[21]  Joseph G Ibrahim,et al.  A General Class of Bayesian Survival Models with Zero and Nonzero Cure Fractions , 2005, Biometrics.

[22]  J. Boag,et al.  Maximum Likelihood Estimates of the Proportion of Patients Cured by Cancer Therapy , 1949 .

[23]  A Yu Yakovlev,et al.  Stochastic Models of Tumor Latency and Their Biostatistical Applications , 1996 .

[24]  Yingwei Peng,et al.  An extended cure model and model selection , 2012, Lifetime data analysis.

[25]  Leonid Hanin,et al.  Identifiability of cure models revisited , 2014, J. Multivar. Anal..

[26]  Franklin J. Hickman Handbook for Survival. , 1977 .

[27]  Janez Stare,et al.  On Estimation in Relative Survival , 2012, Biometrics.

[28]  Joseph G. Ibrahim,et al.  Cure rate models: A unified approach , 2005 .

[29]  Bradley P Carlin,et al.  Flexible Cure Rate Modeling Under Latent Activation Schemes , 2007, Journal of the American Statistical Association.

[30]  SMOOTHING COVARIATE EFFECTS IN CURE MODELS , 2002 .

[31]  Ning Liu,et al.  STATISTICAL ISSUES INVOLVED WITH EXTENDING STANDARD MODELS , 2007 .

[32]  Lena Viall Where is the Cure? , 1907, California state journal of medicine.